Neoplasia/BPH

	Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study. Minerva Urol Nephrol Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M. PMID: 42334408 [PubMed - as supplied by publisher]
	Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol. J Endourol Singh G, Bakbak H, Abdelaziz A, Resnik S, Ospina JV, Katz JE, Marcovich R, Khandekar A, Punnen S, Gonzalgo ML, Parekh DJ, Shah HN. PMID: 42333981 [PubMed - as supplied by publisher]
	UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation. PeerJ Qin T, Liang J, Ya W, Long Y, Wu J, Meng D, Gan F. PMID: 42333228 [PubMed - in process]
	Hugoâ„¢ RAS versus da Vinci(Â®) for robot-assisted radical prostatectomy in localized prostate cancer: a GRADE-assessed systematic review and meta-analysis of prospective comparative studies. BMC Surg Mirza W, Haider MH, Habib T, Ali RN, Moeen-Ud-Din MB, Hadhoud AM. PMID: 42332746 [PubMed - as supplied by publisher]
	Exploring the relationship between potential hepatotoxicity and novel hormonal therapies in prostate cancer: a systematic review and meta-analysis. BMC Cancer Ma L, Fan L, Luo X, Huang Z, Dai J, Wu Y, Zhang W. PMID: 42332688 [PubMed - as supplied by publisher]
	A stratified urine-based molecular diagnostic and prognostic model for non-muscle-invasive bladder cancer management. BMC Cancer Yi L, Ma Z, Zhang J, Zhan Y, Xiao H, Dai K, Liu Y, Gao Y, Yang X, Cao D, Xu D, Huang H. PMID: 42332658 [PubMed - as supplied by publisher]
	The burden of cardiovascular disease in prostate cancer: prevalence, pathophysiology, and implications for integrated care. Support Care Cancer Ogieuhi IJ, Anthony CS, Ajekiigbe VO, Ayomikun AF, Iyawe EP, Adegbesan CA, Adeshina GA, Moradeyo A, Akingbola A, Ogunniyi KE. PMID: 42332138 [PubMed - indexed for MEDLINE]
	Comment on: cardiovascular and prostate cancer risk associated to testosterone replacement therapy-a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sansone A, Jannini EA. PMID: 42332077 [PubMed - as supplied by publisher]
	PROTEUS trial heralds perioperative therapy for prostate cancer. Nat Med O'Leary K. PMID: 42331980 [PubMed - as supplied by publisher]
	Parental occupational exposure to pesticides at birth and risk of adult testicular germ cell tumours in offspring: a French nationwide case-control study. Occup Environ Med Paul A, Danjou A, Coste A, Kromhout H, Lefevre M, Spinosi J, Dananché B, Olsson A, Lamouroux C, Guth M, Béranger R, Pérol O, Boyle H, Hersant C, Loup-Cabaniols V, Veau S, Perrin J, Schüz J, Charbotel B, Fervers B, TESTIS study group. PMID: 42331594 [PubMed - as supplied by publisher]
	Optimising the prostate cancer diagnostic pathway in a tertiary hospital in Karachi: a two-cycle quality improvement project. BMJ Open Qual Samad S, Samad H. PMID: 42331392 [PubMed - indexed for MEDLINE]
	Predicting Renal Tumor Pathology from Intraoperative Gross Appearance: An AI-Based Pilot Study. Urology Patel MH, Lodha R, Millan B, Blachman-Braun R, Loebach L, Pramod N, Saini J, Koller C, Stecko H, Gurram S, Turkbey B, Linehan WM, Ball MW. PMID: 42331293 [PubMed - as supplied by publisher]
	Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological study. Tissue Cell Fantone S, Tossetta G, Sanguedolce F, Goteri G, Marzioni D, Mazzucchelli R. PMID: 42330802 [PubMed - as supplied by publisher]
	Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up. Ann Intern Med Palsdottir T, Micoli C, Eklund M, Grönberg H, Jäderling F, Tilki D, Lin DW, Cooperberg MR, Eggener SE, Oeffinger KC, Nordström T, Vigneswaran HT. PMID: 42330502 [PubMed - as supplied by publisher]
	Summary for Patients: Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study. Ann Intern Med PMID: 42330499 [PubMed - as supplied by publisher]
	Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway. PLoS One Ou Y, Ye C, Jiang H, Zhu Y, Xia C, Yang D. PMID: 42329914 [PubMed - indexed for MEDLINE]
	A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia - Sex Hormone And Urinary Control Effects. J Vis Exp Wu Y, Ma W. PMID: 42329844 [PubMed - indexed for MEDLINE]
	A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging. Nucl Med Commun Hooda M, Sharma AP, Watts A, Aggarwal P, Mavuduru R, Singh H, Kakkar N, Singh SK, Singh B. PMID: 42329706 [PubMed - as supplied by publisher]
	Jaboticaba peel extract limits castration-resistant prostate cancer aggressiveness by counteracting EMT through steroid hormone and TGF-Î² signaling modulation. J Mol Histol Schievano FR, de Souza Gianchetto J, Santos FR, Maróstica Júnior MR, Cagnon VHA, Montico F. PMID: 42329344 [PubMed - indexed for MEDLINE]
	Research trends and collaboration patterns in robotic retroperitoneal lymph node dissection for testicular cancer. J Robot Surg Demir DÖ, Öktem Ç, Gökkurt Y, Bayraktar AB, Varan A. PMID: 42329300 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188818

Page 1 of 9441



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy